Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Chan DC, Watts GF, Redgrave TG, Mori TA, Barrett PHR . Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism 2002; 51: 1041–1046.
Thompson GR, Naoumova R, Watts GF . Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res 1996; 37: 439–447.
Riches FM, Watts GF, Hua J, Stewart GR, Naoumova RP, Barrett PH . Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. J Clin Endocrinol Metab 1999; 84:2854–2861.
Simonen PP, Gylling H, Howard AN, Miettinen TA . Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000; 72: 82–88.
Miettinen TA, Tilvis RS, Kesaniemi YA . Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990; 131: 20–31.
Gylling H, Miettinen TA . Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men. J Lipid Res 1996; 37: 1776–1785.
Simonen PP, Gylling H, Miettinen TA . Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes Res 2002; 10: 328–335.
Watts GF, Naoumova RP, Kelly JM, Riches FM, Croft KD, Thompson GR . Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. Am J Physiol 1997; 273: 462–470.
Watts GF, Cummings MH, Umpleby M, Quiney JR, Naoumova R, Thompson GR . Sonksen PH. Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications. Eur J Clin Invest 1995; 25: 559–567.
Lindenthal B, Sudhop T, Schiedermaier P, Agnan M, Sauerbruch T, von Bergmann K . Serum plant sterols and biliary cholesterol secretion in humans: studies with ursodeoxycholic acid. J Lipid Res 2002; 43: 1072–1077.
Duane WC, Hunninghake DB, Freeman ML, Pooler PA, Schlasner LA, Gebhard RL . Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology 1988; 8:1147–1150.
Vanhanen H, Kesäniemi YA, Miettinen TA . Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids and cholesterol absorption in man. Metabolism 1992; 41: 588–595.
Duane WC . Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects. J Clin Invest 1993; 92: 911–918.
Sehayek E, Ono JG, Shefer S, Nguyen LB, Wang N, Batta AK, Salen G, Smith JD, Tall AR, Breslow JL . Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci 1998; 95: 10194–10199.
Ostlund RE, Bosner MS, Stenson WF . Cholesterol absorption efficiency declines at moderate dietary doses in normal human subjects. J Lipid Res 1999; 40: 1453–1458.
Kesaniemi YA, Grundy SM . Overproduction of low density lipoproteins associated with coronary heart disease. Arteriosclerosis 1983; 3: 40–46.
Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ, Despres JP . Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955–1961.
Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA, Knopp RH, Lipka LJ, Lebeaut AP, Yang B, Mellars LE, Cuffie-Jackson C, Veltri EP, Ezetimibe Study Group. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther 2001; 23: 1209–1230.